• Peripheral vascular disease is often associated with diabetes mellitus in man. 1 The nature of the processes which lead to the development of this vascular pathology are not understood. A possible explanation for the appearance of the vascular disease might be that the diabetic becomes abnormally sensitive to the vasoconstrictor effects of the endogenous catecholamines, epinephrine and norepinephrine. An increase in responsiveness of the peripheral vessels to catecholamines could result from an impairment in function of the sympathetic fibers which innervate these vessels, i.e., the lesion might finally result in a condition analogous to denervation sensitization. The clinical observation that diabetes may induce neuropatfiy of the sympathetic nervous system 2 ' 3 lends support to the present hypothesis.
The experiments reported here were performed to determine a) if the experimental animal with chronic diabetes mellitus exhibits enhanced vascular reactivity to several vasoconstrictor agents, and b) whether such an alteration of vascular responsiveness might result from a sympathetic neuropathy induced by the diabetic state.
Methods
Male Long-Evans strain rats weighing 200 to 350 g were used for these experiments. The animals were allowed free access to food and water, and only animals received in the same shipment 494 were used for comparison. Rats were made diabetic by the subcutaneous administration of 150 mg/kg of alloxan (1.5% solution). Solutions of alloxan were prepared immediately before injection. Five to ten per cent of the animals treated in this way died; about ten per cent did not show elevated blood glucose levels and were considered "alloxan treated nondiabetic."
Approximately one month after injection of alloxan animals that exhibited glucosuria (Lilly Tes-Tape) were selected as diabetics. Diabetes was confirmed by determining glucose concentrations (Somogi) 4 in 0.2 ml of blood withdrawn from the tubing immediately after the cannulation described below. Only animals with blood glucose levels greater than 200 mg % were considered to be diabetic.
Vascular responses were measured in the isolated perfused hindquarters of control, diabetic, and reserpine-treated (1 mg/kg daily for five days) rats using a technique previously described in detail by Brody et al. 5 Animals were anesthetized with 30 to 50 mg/kg of pentobarbital sodium administered intraperitoneally as a 5% solution. The abdominal aorta was ligated and doubly cannulated. Blood was diverted from the upper cannula through Tygon tubing which was inserted into a Sigmamotor pump. The pump propels the blood into the hindquarters via the caudal cannula permitting estimation of changes in resistance which are proportional to changes in perfusion pressure at constant flow. Blood pressure and perfusion pressure were monitored using Statham arterial pressure transducers. Flow was adjusted until perfusion pressure was approximately equal to blood pressure. Intra-arterial injections were made into the cannula leading to the limbs. Drugs were injected with a 50-microliter microsyringe (Hamilton Company, Inc.) in a volume of 0.002 to 0.006 ml. All doses were expressed as the free base. The lumbar sympathetic chains were isolated and electrically stimulated through a small bipolar electrode with square wave pulses from a Grass stimulator.
Responses of isolated atria from diabetic and control rats were measured in animals sacrificed by a hard blow on the neck. The heart was excised and immediately placed in Feigen's solution '• aerated with 95% oxygen-5% carbon dioxide. The atria were dissected free, and placed in a 7.5 ml bath maintained at 32°C. Tension was recorded with a Statham force transducer; rate was determined from the tension record. In all experiments, the initial tension on the muscle was set at 250 mg. Drugs were added to the bath and were washed out following the peak effect.
Urinary excretion of catecholamines was determined using the procedure of von Euler and Lishajko. 7 The animals were placed in Tygoncoated stainless steel metabolism cages five hours prior to the beginning of the 24-hour collection period. The urine was collected in polyethylene bottles containing sufficient concentrated hydrochloric acid to maintain the pH below 2. Animals were allowed free access to food and water.
Statistical procedures for the six point bio-assays are those described by Finney. s Data reported met all the criteria required for the use of this method. Other tests for significance were taken from Snedecor. 9 All results listed in the tables are presented as means plus or minus standard deviations.
Drugs utilized in this study included epinephrine hydrochJoride, norepinephrine bitartrate, tyramine hydrochloride, valine 5-angiotensin n amide (Ciba), barium chloride, reserpine (Serpasil, Ciba), and phenyl-alanyl 2-lysyl 8-vasopressin (PLV 2 , Sandoz). Effect of norepinephrine, epinephrine, and sympathetic nerve stimulation upon perfusion pressure in hindquarters of diabetic and control rats. Means and calculated regression lines from 11 animals in each group are graphed. Potency ratio (R) and its 95% confidence intervals are listed for norepinephrine and epinephrine. Values for nerve stimulation are not significantly different. Panel C: responses to bilateral lumbar sympathetic nerve stimulation at 1, 2, and 4 volts; 20 cycles/sec; 2 msec duration. Panel D: responses to bilateral lumbar sympathetic nerve stimulation at 5, 10, and 20 cycles/sec; 10 volts; 2 msec duration. All nerve stimulations were of 5-second duration. diabetic rat to the intra-arterial administration of epinephrine and norepinephrine as well as to electrical stimulation of the sympathetic chains. Constrictor effects of the catecholamines were significantly greater in the diabetic animals than in control animals, as is seen in figure 2. Calculated regression lines of dose-response relationships are presented for norepinephrine (panel A) and epinephrine (panel B). The potency ratio (R) was determined for each amine and was found to be statistically significant. Values of R, ap-proximately 2.6 for both amines, indicate that one dose unit of amine produced an effect in the diabetic rats equivalent to 2.6 units of drug in the control rats.
Results
Panels C and D of figure 2 illustrate responses of the perfused vessels to electrical stimulation of the lumbar sympathetic chains. It can be seen that nerve stimulation at varied voltages or varied frequencies (at supramaximal voltage) elicited pressor responses in the diabetic animals which were not significantly different from those of the control group. table 1 show that the perfusion pressures at which the experiments were performed were not significantly different between control and diabetic groups. However, vascular resistance in the diabetic animals was significantly higher, resulting in average flows that were 25% lower. The difference in flow could not account for the significant increase in responsiveness of the diabetics to catecholamines. Based on the magnitude of the flow differential diabetic rats might have received an average concentration of drug 1.3 times as great as controls. However, as was seen in figure 2 * Values represent means plus or minus standard deviations of five atria from each group except in the case of barium where n = 4. There are no significant differences between responses of diabetic and control atria for any of the drugs tested. responded as if they were exposed to a concentration of catecholamine 2.6 times as great (potency ratio equals 2.6). Second, in each group there was no correlation between individual flows and magnitude of vasconstriction, i.e., the lowest flows did not result in the largest constrictions. Results obtained with intra-arterial injection of two other constrictor agents are listed in table 2. Reactivity of the diabetic group to tyramine was unaltered, whereas the responses to synthetic angiotensin were significantly greater.
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Responses of isolated atria from five diabetic and five control rats are listed in table 3. As can be seen, the increased reactivity to the catecholamines observed in the vessels of the hindquarters was not noted in cardiac tissue.
There were no significant differences between the groups in either inotropic or chronotropic responses to epinephrine, norepinephrine, tyramine, or barium chloride.
Urinary excretion of catecholamines was determined in five control and five diabetic animals. The total excretion of catecholamines expressed as yu. g norepinephrine/kg/24 hr was 2.16 ±0.82 for the control animals and 4.77 ± 2.38 for the diabetic group. The values were significantly different (P<0.05). Urine volumes for the two groups were 12 ± 3 ml and 137 ± 25 ml respectively.
In order to provide a situation analogous to sympathetic denervation, rats were treated with reserpine, 1 mg/kg IP, for five days. Table 4 shows that rats treated with reserpine are significantly more responsive to epineph-rine and norepinephrine than are control animals. Conversely, the effects of lumbar stimulation were markedly reduced in the treated group. Data are also presented in table 3 to indicate that the reserpine-treated rat is not more sensitive to tyramine, angiotensin, vasopressin, or barium.
An alloxan-treated rat that develops diabetes fails to gain weight at the same rate as do shipment controls (table 5). All doses in these experiments were given on an absolute basis. If these doses are calculated on a per kilogram basis the diabetic rat appears to receive a larger dose than do control animals. To rule out the discrepancy in size of the two groups of animals as an apparent mechanism for the increased sensitivity, vascular responses were determined in groups of animals weighing approximately 200 and 300 grams. These weights approximate those of our experimental groups (table 5). It was shown that vascular responses were not significantly different in these two groups of animals.
A direct effect of alloxan per se was tested in four experiments where the vascular responsiveness of alloxan-treated nondiabetic rats (see Methods) was compared to control rats. Vasoconstrictor effects of epinephrine t This average weight approximates that of diabetic group shown in figure 1 (229 ± 38) .
{ This average weight approximates that of control group shown in figure 1 (335 ± 3 6 ) .
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and norepinephrine were the same in the two groups.
Discussion
The results of this investigation indicate that rats with alloxan diabetes of one month's duration exhibit vascular hyperresponsiveness to epinephrine, norepinephrine, and angiotensin. Several of the factors or mechanisms which might be responsible for the altered vascular reactivity were considered. Considerable attention was directed toward evaluation of the hypothesis that increased sensitivity of the diabetic animals might result secondarily from impairment of normal sympathetic function, i.e., sympathetic neuropathy. The data do not appear to be consistent with this hypothesis for the following reasons: a) responses to electrical stimulation of the lumbar sympathetic chains are unaltered by the diabetic state, b) angiotensin produces an exaggerated response in diabetic but not in reserpinized animals, c) responses to tyramine are unchanged in the diabetic rat, d) diabetic rats excrete catecholamines at a faster rate than control animals, and e) isolated atria from diabetic animals do not demonstrate hyperresponsiveness in parallel with that observed in the vasculature of the hindquarters.
Results obtained with sympathetic nerve stimulation, which showed no difference in vasoconstrictor effects between diabetics and controls, suggest that the diabetic state does not induce a malfunction of these nerves. It has not been determined, however, why the hindquarter vessels of diabetic animals should be more responsive to exogenous norepinephrine than to endogenous norepinephrine released from the sympathetic terminals.
Alterations in normal sympathetic activity affect vascular responses to angiotensin and tyramine. In the dog the local constrictor effect of angiotensin on the perfused hindquarters is significantly reduced by acute sympathectomy. 10 The responsiveness of the rat to angiotensin is unaffected by chronic immunological sympathectomy. 11 The sympathomimetic actions of tyramine are virtually abollished following loss of norepinephrine tissue stores, e.g., following treatment with reser-pine. 12 The fact that diabetic animals exhibited enhanced reactivity to angiotensin and unaltered reactions to tyramine provides indirect evidence for the integrity of the sympathetic nervous system in these rats. It should also be noted that following "pharmacological denervation" with reserpine the perfused vessels were sensitized only to the catecholamines and not to angiotensin, vasopressin, or barium chloride.
Further evidence that alloxan diabetes does not produce a loss of adrenergic function is found in the results of the experiments on isolated atria. Atria from diabetic animals responded in normal fashion to the addition of the catecholamines. If a generalized sympathetic lesion were the causal factor in the development of increased vascular sensitivity, it would be expected that cardiac muscle would be similarly involved since this tissue also exhibits supersensitivity following denervation. 13 In view of the other evidence presented for the integrity of the sympathetics it seems unlikely that the atria responded normally because their innervation was unaffected while the innervation of the hindquarter vessels was specifically affected by the diabetes.
It may be concluded that no evidence was found to support the hypothesis that increased vascular reactivity in alloxan diabetes results from a condition analogous to denervation sensitivity. Other variables in these experiments which might have contributed to the increased vascular reactivity observed in diabetic animals were the effect of alloxan per se and the difference in body weight between control and diabetic groups. It is rather unlikely that alloxan could produce sensitization of the hindquarter vasculature. The compound is quite unstable in the body producing its effect on pancreatic islet cells in the very short time before it is broken down. 14 These experiments were performed one month following the administration of alloxan when the material could no longer have been present to exert any effect upon blood vessels. More importantly, alloxan-treated nondiabetic rats responded normally to constrictor stimuli when tested at the same time as companion diabetic animals. Diabetic animals failed to gain weight at the same rate as controls and thus received larger doses of constrictor drugs when these doses are expressed on a per kilogram basis. The demonstration that nondiabetic animals of equal weight were not more sensitive to the catecholamines and angiotensin would seem to rule out the possibility that the diabetics were in fact receiving a "larger dose" of drug.
Reports are available in the literature which are in agreement with the results presented here, i.e., that the diabetic animal exhibits enhanced vascular reactivity. Poe and Davis 15 observed a higher incidence of tail gangrene in alloxan diabetic rats following cold injury. This reaction might well have occurred from a more intense protective vasoconstriction in the diabetics. Stone et al. 10 showed that diabetic patients with orthostatic hypotension exhibited exaggerated systemic blood pressure responses to the intravenous infusion of norepinephrine.
In conclusion it has been demonstrated that blood vessels in the hindquarters of alloxan diabetic rats are abnormally sensitive to the constrictor stimuli of epinephrine, norepinephrine, and angiotensin. The mechanism responsible for this increase in vascular reactivity is undetermined. Diabetes mellitus in man and the rat have many similarities. It is of interest to speculate whether a common disease process might affect vascular smooth muscle in a similar manner in both species. If this notion were true the present results might bear a relationship to the etiology of peripheral vascular disease in the human diabetic.
Summary
Vascular reactivity was examined in vessels of the perfused hindquarters of alloxan diabetic and control rats. A significant increase was noted in responsiveness of the diabetic animals to intra-arterial injection of epinephrine, norepinephrine, and synthetic angiotensin. No difference was observed in the vasoconstrictor effects of lumbar sympathetic nerve stimulation or intra-arterial administra- tion of tyramine. Results obtained in diabetic animals were compared with those in animals treated with reserpine. It was found that the reserpinized animals exhibited increased vascular responsiveness only to the catecholamines, and not to angiotensin, vasopressin, tyramine, or barium chloride. Whereas the vascular smooth muscle of diabetic rats was sensitized to epinephrine and norepinephrine, isolated atria from these animals responded normally to the catecholamines. The 24-hour urinary excretion of the catecholamines was significantly elevated in diabetic animals. The data suggest that enhanced vascular reactivity seen in diabetic rats does not result from neuropathy of the sympathetic nervous system. The possible contributions of factors including alloxan per se and body weight to development of increased vascular reactivity in diabetes were considered, but the mechanism for the increase in vascular responsiveness remains unidentified.
